View in EDS

Collaborative effect of Csnk1a1 haploinsufficiency and mutant p53 in Myc induction can promote leukemic transformation.

Saved in:
Bibliographic Details
Title: Collaborative effect of Csnk1a1 haploinsufficiency and mutant p53 in Myc induction can promote leukemic transformation.
Authors: Fuchs SNR; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Stalmann USA; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Snoeren IAM; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Bindels E; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Schmitz S; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Banjanin B; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Hoogenboezem RM; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., van Herk S; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Saad M; Department of Cell and Tumor Biology, Faculty of Medicine, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany., Walter W; MLL Munich Leukemia Laboratory, Munich, Germany., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Seillier L; Cancer Research Center Cologne Essen, University Hospital Cologne, Cologne, Germany.; Joint Research Center for Computational Biomedicine, University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany., Saez-Rodriguez J; Heidelberg University, Faculty of Medicine, and Heidelberg University Hospital, Institute for Computational Biomedicine, Bioquant, Heidelberg, Germany., Dugourd AJF; Heidelberg University, Faculty of Medicine, and Heidelberg University Hospital, Institute for Computational Biomedicine, Bioquant, Heidelberg, Germany., Lehmann KV; Cancer Research Center Cologne Essen, University Hospital Cologne, Cologne, Germany.; Joint Research Center for Computational Biomedicine, University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany., Ben-Neriah Y; The Lautenberg Center for Immunology and Cancer Research, Institute of Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel., Gleitz HFE; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Schneider RK; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.; Department of Cell and Tumor Biology, Faculty of Medicine, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany.
Source: Blood advances [Blood Adv] 2024 Feb 13; Vol. 8 (3), pp. 766-779.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38147624
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Collaborative effect of Csnk1a1 haploinsufficiency and mutant p53 in Myc induction can promote leukemic transformation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fuchs+SNR%22">Fuchs SNR</searchLink>; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Stalmann+USA%22">Stalmann USA</searchLink>; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Snoeren+IAM%22">Snoeren IAM</searchLink>; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Bindels+E%22">Bindels E</searchLink>; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Schmitz+S%22">Schmitz S</searchLink>; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Banjanin+B%22">Banjanin B</searchLink>; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Hoogenboezem+RM%22">Hoogenboezem RM</searchLink>; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Herk+S%22">van Herk S</searchLink>; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Saad+M%22">Saad M</searchLink>; Department of Cell and Tumor Biology, Faculty of Medicine, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany.<br /><searchLink fieldCode="AU" term="%22Walter+W%22">Walter W</searchLink>; MLL Munich Leukemia Laboratory, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Haferlach+T%22">Haferlach T</searchLink>; MLL Munich Leukemia Laboratory, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Seillier+L%22">Seillier L</searchLink>; Cancer Research Center Cologne Essen, University Hospital Cologne, Cologne, Germany.; Joint Research Center for Computational Biomedicine, University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany.<br /><searchLink fieldCode="AU" term="%22Saez-Rodriguez+J%22">Saez-Rodriguez J</searchLink>; Heidelberg University, Faculty of Medicine, and Heidelberg University Hospital, Institute for Computational Biomedicine, Bioquant, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Dugourd+AJF%22">Dugourd AJF</searchLink>; Heidelberg University, Faculty of Medicine, and Heidelberg University Hospital, Institute for Computational Biomedicine, Bioquant, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Lehmann+KV%22">Lehmann KV</searchLink>; Cancer Research Center Cologne Essen, University Hospital Cologne, Cologne, Germany.; Joint Research Center for Computational Biomedicine, University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany.<br /><searchLink fieldCode="AU" term="%22Ben-Neriah+Y%22">Ben-Neriah Y</searchLink>; The Lautenberg Center for Immunology and Cancer Research, Institute of Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Gleitz+HFE%22">Gleitz HFE</searchLink>; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Schneider+RK%22">Schneider RK</searchLink>; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.; Department of Cell and Tumor Biology, Faculty of Medicine, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2024 Feb 13; Vol. 8 (3), pp. 766-779.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38147624
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2022008926
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 766
    Titles:
      – TitleFull: Collaborative effect of Csnk1a1 haploinsufficiency and mutant p53 in Myc induction can promote leukemic transformation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fuchs SNR
      – PersonEntity:
          Name:
            NameFull: Stalmann USA
      – PersonEntity:
          Name:
            NameFull: Snoeren IAM
      – PersonEntity:
          Name:
            NameFull: Bindels E
      – PersonEntity:
          Name:
            NameFull: Schmitz S
      – PersonEntity:
          Name:
            NameFull: Banjanin B
      – PersonEntity:
          Name:
            NameFull: Hoogenboezem RM
      – PersonEntity:
          Name:
            NameFull: van Herk S
      – PersonEntity:
          Name:
            NameFull: Saad M
      – PersonEntity:
          Name:
            NameFull: Walter W
      – PersonEntity:
          Name:
            NameFull: Haferlach T
      – PersonEntity:
          Name:
            NameFull: Seillier L
      – PersonEntity:
          Name:
            NameFull: Saez-Rodriguez J
      – PersonEntity:
          Name:
            NameFull: Dugourd AJF
      – PersonEntity:
          Name:
            NameFull: Lehmann KV
      – PersonEntity:
          Name:
            NameFull: Ben-Neriah Y
      – PersonEntity:
          Name:
            NameFull: Gleitz HFE
      – PersonEntity:
          Name:
            NameFull: Schneider RK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 02
              Text: 2024 Feb 13
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1